Pricing Log in Create free account

Axsome Therapeutics, Inc. (AXSM) vs Praxis Precision Medicines, Inc. (PRAX)

Axsome Therapeutics, Inc. and Praxis Precision Medicines, Inc. are both Biotechnology companies. Axsome Therapeutics, Inc. and Praxis Precision Medicines, Inc. are of similar size ($7.3B and $6.8B). Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against 54.2%. Praxis Precision Medicines, Inc. has the higher net margin (0.00% vs −18.2%) and the lower return on invested capital (−40.6% vs 0.00%). Across the 17 metrics below, Praxis Precision Medicines, Inc. leads on 9 and Axsome Therapeutics, Inc. on 8.

Valuation

Metric AXSM PRAX Biotechnology median
P/E n/m n/m 10.26
P/S 7.83 900.80 9.18
P/B 64.25 5.75 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 7.61 812.11 8.98
Earnings yield (2.37%) (4.89%) (34.89%)
Free cash flow yield (1.22%) (3.97%) (24.52%)

Profitability

Metric AXSM PRAX Biotechnology median
Gross margin 93.25% 100.00% 65.16%
Operating margin (17.45%) 0.00% 0.00%
Net margin (18.18%) 0.00% 0.00%
Free cash flow margin (9.55%) 0.00% 0.00%
Return on equity (175.59%) (38.86%) (50.12%)
Return on assets (21.03%) (36.80%) (45.60%)
Return on invested capital 0.00% (40.58%) 0.00%

Growth

Metric AXSM PRAX Biotechnology median
Revenue growth (TTM) 54.16% 249.53% 6.26%
EPS growth (last fiscal year) 38.56% (32.03%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AXSM PRAX Biotechnology median
Debt to equity 1.21 0.00 0.00
Current ratio 1.42 15.73 4.89
Net debt to EBITDA 1.29 1.82 1.01

Dividend

Metric AXSM PRAX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AXSM PRAX Biotechnology median
Market cap 6.83b 7.33b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack